Credit Suisse’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $146M | Sell |
|
|||||
|
2023
Q4 | $160M | Sell |
|
|||||
|
2023
Q3 | $172M | Buy |
|
|||||
|
2023
Q2 | $141M | Sell |
|
|||||
|
2023
Q1 | $178M | Buy |
|
|||||
|
2022
Q4 | $160M | Sell |
|
|||||
|
2022
Q3 | $167M | Sell |
|
|||||
|
2022
Q2 | $205M | Buy |
|
|||||
|
2022
Q1 | $173M | Buy |
|
|||||
|
2021
Q4 | $138M | Buy |
|
|||||
|
2021
Q3 | $110M | Sell |
|
|||||
|
2021
Q2 | $137M | Sell |
|
|||||
|
2021
Q1 | $264M | Buy |
|
|||||
|
2020
Q4 | $171M | Buy |
|
|||||
|
2020
Q3 | $194M | Sell |
|
|||||
|
2020
Q2 | $231M | Buy |
|
|||||
|
2020
Q1 | $125M | Buy |
|
|||||
|
2019
Q4 | $105M | Buy |
|
|||||
|
2019
Q3 | $49.9M | Sell |
|
|||||
|
2019
Q2 | $75.7M | Buy |
|
|||||
|
2019
Q1 | $70.1M | Buy |
|
|||||
|
2018
Q4 | $57.5M | Sell |
|
|||||
|
2018
Q3 | $68.1M | Buy |
|
|||||
|
2018
Q2 | $52.4M | Sell |
|
|||||
|
2018
Q1 | $86.4M | Buy |
|
|||||
|
2017
Q4 | $74M | Buy |
|
|||||
|
2017
Q3 | $68.9M | Sell |
|
|||||
|
2017
Q2 | $71.5M | Sell |
|
|||||
|
2017
Q1 | $77.4M | Buy |
|
|||||
|
2016
Q4 | $49.7M | Sell |
|
|||||
|
2016
Q3 | $64M | Buy |
|
|||||
|
2016
Q2 | $60.5M | Buy |
|
|||||
|
2016
Q1 | $49.3M | Buy |
|
|||||
|
2015
Q4 | $73.9M | Buy |
|
|||||
|
2015
Q3 | $53.5M | Sell |
|
|||||
|
2015
Q2 | $97.6M | Buy |
|
|||||
|
2015
Q1 | $90.3M | Sell |
|
|||||
|
2014
Q4 | $93.1M | Buy |
|
|||||
|
2014
Q3 | $75.7M | Sell |
|
|||||
|
2014
Q2 | $64.1M | Buy |
|
|||||
|
2014
Q1 | $41.6M | Sell |
|
|||||
|
2013
Q4 | $51.2M | Buy |
|
|||||
|
2013
Q3 | $42.6M | Sell |
|
|||||
|
2013
Q2 | $47.5M | Buy |
|